A recent study led by Dr. XIE Dong’s group from Shanghai Institute of Nutrition and Health of the Chinese Academy of Sciences revealed the role and mechanism of ARID2 in liver cancer metastasis, providing therapeutic targets for treatment of hepatocellular carcinoma (HCC). This study was published online in PNAS on Feb 18.
Read More
Health Rss 